|
注册号: Registration number: |
ChiCTR2400080271 |
|
最近更新日期: Date of Last Refreshed on: |
2024-01-25 08:35:27 |
|
注册时间: Date of Registration: |
2024-01-25 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
慢性呼吸道疾病患者对呼吸康复的知识、态度和实践 |
|
Public title: |
Knowledge, Attitudes, and Practices of Patients with Chronic Respiratory Diseases towards Respiratory Rehabilitation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
慢性呼吸道疾病患者对呼吸康复的知识、态度和实践 |
|
Scientific title: |
Knowledge, Attitudes, and Practices of Patients with Chronic Respiratory Diseases towards Respiratory Rehabilitation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
苏林 |
研究负责人: |
魏双 |
|
Applicant: |
Lin Su |
Study leader: |
Shuang Wei |
|
申请注册联系人电话: Applicant telephone: |
+86 134 5345 9527 |
研究负责人电话:
Study leader's |
+86 180 6208 7116 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
cmu_sl@126.com |
研究负责人电子邮件: Study leader's E-mail: |
wsdavid2001@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
山西省太原市小店区龙城大街99号山西白求恩医院 |
研究负责人通讯地址: |
山西省太原市小店区龙城大街99号山西白求恩医院 |
|
Applicant address: |
Shanxi Bethune Hospital, No. 99, Longcheng Street, Xiaodian District, Taiyuan City, Shanxi Province |
Study leader's address: |
Shanxi Bethune Hospital, No. 99, Longcheng Street, Xiaodian District, Taiyuan City, Shanxi Province |
|
申请注册联系人邮政编码: Applicant postcode: |
030032 |
研究负责人邮政编码: Study leader's postcode: |
030032 |
|
申请人所在单位: |
山西白求恩医院(山西医学科学院) |
||
|
Applicant's institution: |
Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences) |
||
|
研究负责人所在单位: |
山西白求恩医院(山西医学科学院) |
||
|
Affiliation of the Leader: |
Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences) |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
NO.LYLL-2023-002/PJ04 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
山西白求恩医院(山西医学科学院)临床研究伦理委员会 |
||
|
Name of the ethic committee: |
Clinical Research Ethics Committee of Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences) |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-10-23 00:00:00 | ||
|
伦理委员会联系人: |
赵俊康 |
||
|
Contact Name of the ethic committee: |
Junkang Zhao |
||
|
伦理委员会联系地址: |
山西省太原市小店区龙城大街99号山西白求恩医院 |
||
|
Contact Address of the ethic committee: |
Shanxi Bethune Hospital, No. 99, Longcheng Street, Xiaodian District, Taiyuan City, Shanxi Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 186 3451 9089 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
山西白求恩医院(山西医学科学院) |
||||||||||||||||||||||
|
Primary sponsor: |
Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences) |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
山西省太原市小店区龙城大街99号山西白求恩医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Shanxi Bethune Hospital, No. 99, Longcheng Street, Xiaodian District, Taiyuan City, Shanxi Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
2022年度山西省高校科技创新项目(2022L160)、山西白求恩医院新冠感染应急攻关科研专项重点项目(2023XG01)、2023年度山西省卫生健康委员会新冠研究项目(No.2023XG001、No.2023XG005)、山西省“四个一批”科技兴医创新计划(2023XM003)、山西白求恩医院肿瘤专项基金研究项目(No. 2020-ZL04),山西省卫生健康委员会外聘专家工作室项目(黄河教授山西蛋白质组学工作室) |
||||||||||||||||||||||
|
Source(s) of funding: |
Science and Technology Innovation Project of Shanxi Universities in 2022 (2022L160), the Key Scientific Research Project of COVID-19 Infection Emergency Treatment of Shanxi Bethune Hospital (2023xg01), 2023 COVID-19 Research Project of Shanxi Provincial Health Commission (No.2023XG001, No. 2023XG005), Four "Batches" Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province (2023XM003), Cancer special Fund research project of Shanxi Bethune Hospital (No. 2020-ZL04), and External Expert Workshop Fund Program of Shanxi Provincial Health Commission(Proteomics Shanxi studio for Huanghe professor) |
||||||||||||||||||||||
|
研究疾病: |
慢性呼吸道疾病 |
||||||||||||||||||||||
|
Target disease: |
Chronic Respiratory Diseases |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
调查慢性呼吸道疾病患者对呼吸康复的认知、态度想法和行为实践,结合调查对象的社会人口学特征,对其影响因素进行分析,为制定科学的干预策略提供依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate the cognition, attitude, thoughts and behavioral practices of patients with chronic respiratory diseases on respiratory rehabilitation, and to analyze the influencing factors of respiratory rehabilitation based on the sociodemographic characteristics of the respondents, so as to provide a basis for formulating scientific intervention strategies. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
不同意参加调查研究的患者、无法完成问卷的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patients who do not agree to participate in the survey study, patients who are unable to complete the questionnaire. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-01-25 00:00:00至 To 2024-02-10 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-01-25 00:00:00 至 To 2024-02-10 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2024年2月10日,邮箱 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
February 10, 2024, Mailbox |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
发放问卷 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Questionnaires are distributed |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |